BYD and Alibaba among big names aiding China’s military, Pentagon says Updated Pentagon list includes swathe of China’s top technology firms in move that could inflame tensions between the countries The Guardian - UK · Jun 9
US says BYD, Baidu and Alibaba and other tech giants are aiding China's military The U.S. has updated its list of Chinese companies aiding Beijing's military, adding tech giants like Alibaba and Baidu, alongside chipmakers CXMT and YMTC. This move, superseding a 2025 list, could heighten U.S.-China tensions and impact firms through future contracting restrictions. The Economic Times · Jun 9
US says BYD, Baidu and Alibaba are aiding China's military America has released a new list of Chinese companies it believes support Beijing's military. Major firms like Alibaba, Baidu, and BYD are included. Other companies like WuXi AppTec and RoboSense Technology are also on the list. While not imposing immediate sanctions, the Pentagon will stop contracting with these firms in… The Economic Times · Jun 8
Peter Mandelson’s lobbying firm hired by company linked to Chinese military Global Counsel signed $3m contract with WuXi AppTec in Europe months after it was named in US national security drive The Guardian - UK · Nov 27, 2025
Congress targets Chinese influence in health tech. It could come with tradeoffs A San Jose-based biotechnology company that helps doctors detect genetic causes for cancer is among those that could be cut out of the U.S. market over ties to China The Independent UK · Sep 13, 2024
Stock Index Futures Muted Ahead of U.S. Presidential Debate, Inflation Data Awaited September S&P 500 E-Mini futures (ESU24) are up +0.03%, and September Nasdaq 100 E-Mini futures (NQU24) are down -0.04% this morning as investors looked ahead to the U.S. presidential debate between Donald Trump and Kamala Harris, while also awaiting Wednesday’s release of a key U.S. inflation report. Barchart · Sep 10, 2024
US House Passes Bill To Restrict Business With China's WuXi AppTec, BGI The Biosecure Act would prohibit the U.S. from entering into contracts with the targeted firms, along with those who support them. International Business Times · Sep 10, 2024
Stock Index Futures Inch Lower Ahead of U.S. Presidential Debate, Inflation Data Awaited September S&P 500 E-Mini futures (ESU24) are down -0.07%, and September Nasdaq 100 E-Mini futures (NQU24) are down -0.27% this morning as investors looked ahead to the U.S. presidential debate between Donald Trump and Kamala Harris, while also awaiting Wednesday’s release of a key U.S. inflation report. Barchart · Sep 10, 2024
US Bill Revised To Restrict Wuxi Apptec, Chinese Biotechs US bill revised to address concerns over Chinese biotech firms collaborating with US institutions. Top News · May 10, 2024
Wuxi Apptec Shared US Client Data With Beijing US officials express concerns over WuXi AppTec sharing data with China, highlighting risks in cross-border collaborations. Top News · Mar 28, 2024
Biotech Association To Split With China's Wuxi Apptec US biotech trade association ends ties with WuXi AppTec over IP theft concerns, highlighting challenges in cross-border collaborations. Top News · Mar 14, 2024
US Senate Bill Targets China's BGI And Wuxi Apptec US Senate committee discusses bill targeting Chinese genetic companies for data privacy concerns. Top News · Mar 6, 2024
US Lawmakers Demand Sanctions on China's WuXi AppTec Biotech Firm US lawmakers are urging for sanctions on WuXi AppTec, a Chinese biotech firm. Learn more about the concerns and potential consequences. Top News · Feb 13, 2024
US Bill Poses Risk to Wuxi AppTec and Western Drugmakers Learn about the potential risks facing Wuxi AppTec and its Western drugmaker partners due to a new US bill, impacting their business operations. Stay informed! Top News · Feb 5, 2024
Benzinga · Oct 24, 2022 What Pandemic? Joinn Lab Posts Bumper Profit Despite Covid Disruptions Key Takeaways: Joinn Lab’s net profit in the first three quarters of this year surpassed the figure for all 2021 as the company rapidly expanded its capacity The company is strongly positioned due to high barriers to entry, and a broad presence in its industry chain through its acquisition of…
Benzinga · Jun 7, 2022 CStone Pharma Replaces Chairman Amid Huge Losses, Irregular Investment Key Takeaways: CStone brought four products to market last year, and its losses have surged due to growing R&D and sales spending Appointment of chairman with close ties to WuXi AppTec reveals a power struggle between shareholders and management By Molly Wen